HB Wealth Management’s Bristol-Myers Squibb BMY Stock Holding History
Bought
Maintained
Sold
Other funds holding BMY
VCM
VPM
HB Wealth Management's BMY Position: Q1 2026 in Review
HB Wealth Management increased its Bristol-Myers Squibb (BMY) stake by 26% in Q1 2026, buying an estimated $1.33M and bringing the position to 109,993 shares worth $6.67M. The position accounts for 0.04% of the portfolio, ranked #211.
HB Wealth Management first reported a position in BMY in Q4 2021 and has held it in 18 quarters since. 2,519 funds tracked by Wall St. Rank hold BMY as of Q1 2026.
- HB Wealth Management held 109,993 shares of Bristol-Myers Squibb worth $6.67M as of Q1 2026.
- HB Wealth Management bought 22,867 Bristol-Myers Squibb shares in Q1 2026, an estimated $1.33M.
- Bristol-Myers Squibb made up 0.04% of HB Wealth Management's portfolio in Q1 2026, its #211 holding.
- HB Wealth Management first reported a position in Bristol-Myers Squibb in Q4 2021 and has held it in 18 quarters since.
- 2,519 funds tracked by Wall St. Rank held Bristol-Myers Squibb as of Q1 2026.
Based on HB Wealth Management's 13F filing for Q1 2026, filed 27 Apr 2026.